Systemic Treatment Selection for Patients with Advanced Pancreatic Neuroendocrine Tumours (PanNETs)

Systemic Treatment Selection for Patients with Advanced Pancreatic Neuroendocrine Tumours (PanNETs)

Pancreatic neuroendocrine tumours (PanNETs) are rare diseases and a good example of how research is not only feasible, but also of crucial importance in the scenario of rare tumours. Many clinical trials have been performed over the past two decades expanding therapeutic options for patients with ad...

Full description

Bibliographic Details
Main Authors: Vera G. Megdanova-Chipeva, Angela Lamarca, Alison Backen, Mairéad G. McNamara, Jorge Barriuso, Sonia Sergieva, Lilia Gocheva, Was Mansoor, Prakash Manoharan, Juan W. Valle
Format: Article
Language:English
Published: MDPI AG 2020-07-01
Series:Cancers
Subjects:
treatment
chemotherapy
PRRT
targeted therapy
pancreatic
somatostatin analogues
Online Access:https://www.mdpi.com/2072-6694/12/7/1988

Internet

https://www.mdpi.com/2072-6694/12/7/1988

Similar Items